“If we want to understand consciousness, we must be willing to question everything we think we know about reality.”

Join me today as I sit down with Dr. Dean Radin, Chief Scientist at the Institute of Noetic Sciences, whose career journeys from the creative world of concert violin to the rigorous labs of Bell Labs, Princeton, and pioneering consciousness research. In this candid and wide-ranging conversation, we explore the fascinating intersections of quantum physics, creativity, genetics, health innovation, and the frontier science of mind-matter interaction.

We begin with Dean’s personal story: growing up in an artistically gifted family, being steeped in curiosity and creativity, and how these roots inspired his eventual leap from engineering and AI to psychology and the experimental study of consciousness. Dean shares how early disappointments in theoretical work led him to become an empiricist—someone compelled to test the world and chase anomalies rather than settle for conformity.

Hear Dean recount how his fascination with “truth revealed by anomalies” drew him to the controversial field of parapsychology, conducting experiments on mind-matter interaction at Bell Labs, and being invited into the U.S. government’s Stargate program that investigated psychic espionage. These early experiences, combined with his later leadership at the Institute of Noetic Sciences, led Dean to develop robust, double-blind experiments aimed at probing the subtle ways consciousness might interact with physical systems.

We dive deep into his most intriguing laboratory work—including the famous double-slit experiments, where meditators are tasked with influencing quantum interference patterns, and the illuminating Buddha experiment, a playful blend of neuroscience and gamified feedback. Dean explains what these experiments suggest about the nature of observation, agency, and the mind’s mysterious potential to nudge the physical world, highlighting the vital role of variance and mean shifts in these results.

Beyond the quantum, we talk about Dean’s explorations into genetics and health. Learn how his team is uncovering possible genetic correlates for psychic talent through case-control and 23andMe studies, as well as his foray into neurobiological therapies, applying CRISPR and siRNA via innovative intranasal delivery to mouse models of anxiety and memory. Dean discusses forming companies at the edge of psychiatric medicine: targeting neuromodulation, tailoring temporal effects for sustainable healing, and seeking practical paths from pre-clinical trials to real-world impact.

Dean also addresses skepticism and the challenges of taking creative risks in science. He distinguishes between constructive and ideological skeptics, sharing the strategies he uses to preempt critique and foster robust, transparent research. Dean contends that anti-scientific attitudes rooted in dogmatic disbelief are as limiting as blind acceptance, and champions the value of curiosity-driven, high-risk, high-reward research.

The episode rounds out with reflections on creativity, following one’s bliss, and the deeper purpose of science to expand our collective perception of reality. Listen as Dean shares his thoughts on future breakthroughs, the sociological ramifications of new paradigms, and poses thought-provoking questions about AI, consciousness, and the next phase of scientific evolution.

Whether you come as a scientist, skeptic, innovator, or seeker, this discussion with Dean Radin will stretch your imagination and leave you questioning where the true boundaries of science and health really lie.

Deans homepage: https://www.deanradin.com/

The disclaimer: All chats at entangled health are a co-creation between the guest and myself, and not an official statement from our industries. Guests are here in a personal capacity, as am I, so everything we share is just our own take, not the official view of any company nor of my employer or any other organization.

“Put a bit of passion in everything you do and you will succeed.”

In this episode, Gabriela Cimpan, from Quantinuum, with a background in chemistry and quantum computing, shares her journey from academia to the cutting edge of biotech innovation.

She unpacks the meaning of “entangled health,” drawing on definitions from science and philosophy to show how genetics, environment, and personal choices are deeply interconnected.

Gabriela explains why quantum computing is uniquely suited to tackle complex problems in drug discovery and molecular design, areas where classical computers reach their limits. She illustrates how quantum computers can simulate molecular ground states, a critical challenge in designing new medicines, and how this could lead to breakthroughs in healthcare and materials science.

Gabriela also discusses the synergy between AI and quantum computing, introducing the concept of generative quantum AI (GenQAI). She describes a powerful feedback loop where AI and quantum hardware generate and learn from new data, opening doors to discoveries that were previously impossible. The conversation moves beyond technology, touching on mentorship, the importance of quantum literacy for non-experts, and the societal responsibility of scientists to give back and foster the next generation.

Gabriela shares candid reflections on career choices, the value of passion, and maintaining a critical yet open mindset in a fast-changing field.

Listeners will come away with a deeper understanding of both the promise and the challenges of quantum technology in health, as well as inspiration to pursue interdisciplinary collaboration and lifelong learning.

Links:

https://www.linkedin.com/in/gabrielacimpan/

https://www.quantinuum.com/press-releases/quantinuums-quantum-origin-becomes-first-software-quantum-random-number-generator-to-achieve-nist-validation

The disclaimer: All chats at entangled health are a co-creation between the guest and myself, and not an official statement from our industries. Guests are here in a personal capacity, as am I, so everything we share is just our own take, not the official view of any company nor of my employer or any other organization.

What happens when a quantum computing pioneer discovers the hidden wisdom of native plants? Samarth Sandeep’s journey started with a teenage dream to build a seawater-powered car. Today, he’s CEO of If and Only If Technologies, revolutionizing protein interactions through quantum algorithms and quantum chemistry while challenging how the biotech industry thinks about emerging technologies.

The Environmental Justice Connection

Walking past a red-fenced garden in San Jose, Samarth discovered California Native Garden Foundations’ (CNGF’s) native plant ecosystems that have lower microplastic content than conventional farms’ soils. This wasn’t just about gardening - it inspired and furthered Samarth’s interests around how indigenous plant knowledge could unlock new medicines througg sustainably sourced means .

Quantum vs. LLMs : The Industry Paradox

Here’s what makes this conversation fascinating: Samarth argues that biotech companies embrace unpredictable LLMs but largely view quantum computing as something to take up in the future, even though quantum algorithms have better-understood computational complexities than current LLMs in drug discovery. His QAOA-based protein pruning approach works with current quantum hardware limitations, making it more practical than full quantum docking attempts.

Clinical Breakthroughs

At the start of the COVID-19 pandemic, his quantum algorithms helped to debunk the role of dangerous drug combinations like hydroxychloroquine and azithromycin as potential antivirals impacting SARS-CoV-2’s binding to ACE2, potentially saving lives. His work since then focused on surfactant proteins in COVID-19 . These same lung proteins exist in reproductive tissue, opening new pathways for ovarian cancer research. Additionally, through collaborations with Mount Sinai researchers and others, he’s translating quantum-enhanced protein modeling into clinical practice.

🎧 Ready to explore how environmental stewardship, quantum computing reliability, and protein network discoveries are converging to transform medicine?

Linkedin: https://www.linkedin.com/in/samarth-sandeep-81a02487/

Literature mentioned:

1. Aramyan S, McGregor K, Sandeep S, Haczku A. SP-A binding to the SARS-CoV-2 spike protein using hybrid quantum and classical in silico modeling and molecular pruning by Quantum Approximate Optimization Algorithm (QAOA) Based MaxCut with ZDOCK. Frontiers in Immunology. 2022 Sep 13;13:945317.
2. Montanez-Barrera JA, Michielsen K, Neira DE. Evaluating the performance of quantum processing units at large width and depth. arXiv preprint arXiv:2502.06471. 2025 Feb 10.
3. Yan L, Samarth S, Kirk M, Chandler HP. Developing a Proteomic Framework of Oncopathologies for Rare Hematological Malignancies, like T Lymphomas, through Protein-Protein Interactions to Effectively Connect Patients to Real-World Clinical Trials. In American Journal of Hematology 2022 Oct 1 (Vol. 97, pp. S12-S13)., NJ USA: WILEY. P-018.

Further Links:

Iff Website: https://iff.bio

California Native Garden Foundation Website: cngf.org

The disclaimer: All chats at entangled health are a co-creation between the guest and myself, and not an official statement from our industries. Guests are here in a personal capacity, as am I, so everything we share is just our own take, not the official view of any company nor of my employer or any other organization.